Lipid nanoparticle platform delivers mRNA to the brain

Crossing the blood-brain barrier: Lipid nanoparticle platform delivers mRNA to the brain via intravenous injection
Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge that has long been limited by the protective nature of the blood-brain barrier.
Lipid Nanoparticle Platform Delivers mRNA to the Brain Through the Blood-Brain Barrier
The Mt. Sinai study could open the door to future therapies for Alzheimer’s, amyotrophic lateral sclerosis, brain cancer, and drug addiction.
New Lipid Nanoparticle System Delivers mRNA to the Brain
A new lipid nanoparticle system can deliver messenger RNA (mRNA) to the brain via intravenous injection. | Drug Discovery And Development
Nanoparticles Deliver mRNA to the Brain, Bypassing Blood-Brain Barrier
Scientists have developed a lipid nanoparticle system that enables mRNA to cross the blood-brain barrier, a long-standing challenge in n.
New lipid nanoparticle platform delivers mRNA to the brain through the blood-brain barrier
New York, NY [February 17, 2025]—Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via ...
Promising New Platform for Brain-Targeted mRNA Delivery
Innovative lipid nanoparticles enable mRNA delivery to the brain, offering new avenues for treating neurological disorders by crossing the blood-brain barrier.
Combined organ-specific mRNA and lipid nanoparticle therapy could repair damaged lungs
A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...
News Medical on MSN15h
Targeted mRNA therapy shows promise for healing damaged lungs
A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...
Packing lipid nanoparticles with tumor proteins to boost cancer vaccine potency
The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate cancer in 2010, and another was approved in 2015 for melanoma. Since then, ...
Genprex announces advancement of diabetes program, strategic collaboration
Genprex (GNPX) announced the advancement of its diabetes program through a strategic collaboration with a contract development and ...
News Medical2d
Nanoparticles and Advanced Analytics Accelerate Vaccine Development
Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...